These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 3320342

  • 1. Effects of morphine, ethylketocyclazocine, U-50,488H and naloxone on the acquisition of a classically conditioned response in the rabbit.
    Schindler CW, Gormezano I, Harvey JA.
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1010-7. PubMed ID: 3320342
    [Abstract] [Full Text] [Related]

  • 2. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ, Doty P, Negus SS, Mattox SR, Dykstra LA.
    J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
    [Abstract] [Full Text] [Related]

  • 3. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
    Picker MJ, Dykstra LA.
    J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the discriminative stimulus properties of U50,488 and morphine in pigeons.
    Picker M, Dykstra LA.
    J Pharmacol Exp Ther; 1987 Dec; 243(3):938-45. PubMed ID: 3320348
    [Abstract] [Full Text] [Related]

  • 5. Effects of morphine, ethylketocyclazocine, and N-allylnormetazocine on classical conditioning of the rabbit nictitating membrane response.
    Schindler CW, Lamb MR, Gormezano I, Harvey JA.
    Behav Neurosci; 1986 Oct; 100(5):647-51. PubMed ID: 3535828
    [Abstract] [Full Text] [Related]

  • 6. Further study of kappa opioids on increased urination.
    Leander JD.
    J Pharmacol Exp Ther; 1983 Oct; 227(1):35-41. PubMed ID: 6137557
    [Abstract] [Full Text] [Related]

  • 7. Effect of morphine on acquisition of the classically conditioned nictitating membrane response of the rabbit.
    Schindler CW, Gormezano I, Harvey JA.
    J Pharmacol Exp Ther; 1983 Dec; 227(3):639-43. PubMed ID: 6655560
    [Abstract] [Full Text] [Related]

  • 8. Differential cross-tolerance to opioid agonists in morphine-tolerant pigeons responding under a schedule of food presentation.
    Craft RM, Picker MJ, Dykstra LA.
    J Pharmacol Exp Ther; 1989 May; 249(2):386-93. PubMed ID: 2542528
    [Abstract] [Full Text] [Related]

  • 9. Differential cross-tolerance to opioids in squirrel monkeys responding under a shock titration schedule.
    Craft RM, Dykstra LA.
    J Pharmacol Exp Ther; 1990 Mar; 252(3):945-52. PubMed ID: 1969478
    [Abstract] [Full Text] [Related]

  • 10. Kappa agonists inhibit gastric emptying but not acid secretion in rhesus monkeys.
    Touzeau PL, Shea-Donohue T.
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1010-6. PubMed ID: 1972746
    [Abstract] [Full Text] [Related]

  • 11. Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands.
    Zimmerman DM, Leander JD, Reel JK, Hynes MD.
    J Pharmacol Exp Ther; 1987 May; 241(2):374-8. PubMed ID: 3033213
    [Abstract] [Full Text] [Related]

  • 12. Dexamethasone selective inhibition of acute opioid physical dependence in isolated tissues.
    Capasso A, Di Giannuario A, Loizzo A, Pieretti S, Sagratella S, Sorrentino L.
    J Pharmacol Exp Ther; 1996 Feb; 276(2):743-51. PubMed ID: 8632345
    [Abstract] [Full Text] [Related]

  • 13. Mu-opioid component of the ethylketocyclazocine (EKC) discriminative stimulus in the rat.
    Locke KW, Gorney B, Cornfeldt M, Fielding S.
    Psychopharmacology (Berl); 1989 Feb; 99(4):492-6. PubMed ID: 2556726
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Role of renal nerves in excretory responses to administration of kappa agonists in conscious spontaneously hypertensive rats.
    Kapusta DR, Jones SY, DiBona GF.
    J Pharmacol Exp Ther; 1989 Oct; 251(1):230-7. PubMed ID: 2552076
    [Abstract] [Full Text] [Related]

  • 16. Behavioral effects of a novel kappa opioid analgesic, U-50488, in rats and rhesus monkeys.
    Tang AH, Collins RJ.
    Psychopharmacology (Berl); 1985 Oct; 85(3):309-14. PubMed ID: 3923516
    [Abstract] [Full Text] [Related]

  • 17. Chronic naloxone treatment induces supersensitivity to a mu but not to a kappa agonist at the hypothalamus-pituitary-adrenocortical axis level.
    Alcaraz C, Vargas ML, Fuente T, Milanés MV.
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1602-6. PubMed ID: 8396640
    [Abstract] [Full Text] [Related]

  • 18. Kappa opioids in rhesus monkeys. II. Analysis of the antagonistic actions of quadazocine and beta-funaltrexamine.
    Dykstra LA, Gmerek DE, Winger G, Woods JH.
    J Pharmacol Exp Ther; 1987 Aug; 242(2):421-7. PubMed ID: 3302207
    [Abstract] [Full Text] [Related]

  • 19. U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.
    Vonvoigtlander PF, Lahti RA, Ludens JH.
    J Pharmacol Exp Ther; 1983 Jan; 224(1):7-12. PubMed ID: 6129321
    [Abstract] [Full Text] [Related]

  • 20. Antagonism of the analgesic effects of mu and kappa opioid agonists in the squirrel monkey.
    Dykstra LA, Massie CA.
    J Pharmacol Exp Ther; 1988 Sep; 246(3):813-21. PubMed ID: 2843630
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.